CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing new transplant regimens to enhance the beneficial effects of graft-versus-leukemia while minimizing graft-versus-host disease and infections. It integrates various disciplines to improve cellular therapies for autoimmune diseases and cancers through clinical trials and research.
Novel transplant regimens are currently being developed to improve beneficial GvL effects and reduce GvHD and infections via several new forms of cellular therapies.
This newly emerging supra-disciplinary field of cellular therapy and regenerative medicine is also being used to improve outcomes in autoimmune disease (such as Rheumatoid Arthritis) and cancers.
The goal of this research programme is to gain insight into the mechanisms of action of GvL and GvHD in order to improve current therapies…
UNIVERSITY OF NEWCASTLE UPON TYNE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Norway, Oslo
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
KLINIKUM DER UNIVERSITAET REGENSBURG
Germany, Regensburg
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Hannover
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
MEDIZINISCHE UNIVERSITAET WIEN
Austria, Wien
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
